The RightCall: Implementing a Sepsis Diagnostic Toolkit to Improve Pediatric Diagnosis in ED Transfer Calls
Launched by UNIVERSITY OF COLORADO, DENVER · Jun 24, 2025
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is testing a new toolkit designed to help doctors and nurses recognize sepsis earlier in children who are being transferred from general emergency rooms to a children’s hospital. Sepsis is a serious and potentially life-threatening condition caused by the body’s response to infection. Children treated in general emergency rooms—where adults are also treated—are less likely to be diagnosed with sepsis quickly compared to those treated in specialized children’s emergency rooms. This study will introduce the toolkit into the call center that manages transfers to Children’s Hospital Colorado, aiming to improve how quickly sepsis is identified during the transfer process.
Children eligible for this study are those who are being transferred to Children’s Hospital Colorado for emergency or hospital care and who show signs of sepsis either before or shortly after arriving at the hospital. Babies younger than one month old or those whose transfer call recordings aren’t available won’t be included. Participants won’t need to do anything extra; the study focuses on improving communication between emergency rooms and the children’s hospital through this new toolkit, helping doctors and nurses spot sepsis sooner and provide faster treatment. This could lead to better outcomes for children facing this serious condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Patients transferred to Children's Hospital Colorado (CHCO) for emergency or inpatient care, as identified in the extant CHCO transfer center database AND in the extant CHCO quality improvement sepsis database AND one of the following:
- • Patients who met Phoenix sepsis criteria 1) in the referring ED, 2) during transport, 3) in the first 6 hours after arrival at the pediatric hospital, or 4) patients who developed Phoenix sepsis within 24 hours of arrival at the Children's Hospital underwent independent physician review by three emergency physicians. Patients in whom all three physicians agreed sepsis was most likely present, using the structured SaferDx tool were included
- Exclusion Criteria:
- • Patients less than one month of age
- • Patients whose transfer call recording was not available in the database
About University Of Colorado, Denver
The University of Colorado, Denver, is a leading academic institution dedicated to advancing medical research and improving healthcare outcomes. With a strong emphasis on innovation and collaboration, the university conducts a diverse range of clinical trials aimed at addressing critical health challenges. Its research initiatives are supported by a multidisciplinary team of experts, state-of-the-art facilities, and a commitment to ethical standards and patient safety. By fostering partnerships with local and global communities, the University of Colorado, Denver, strives to translate scientific discoveries into meaningful advancements in clinical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aurora, Colorado, United States
Patients applied
Trial Officials
Halden F. Scott, MD, MSCS
Principal Investigator
University of Colorado School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported